Dana Flavin, MD - Reversing Cancer with Biochemistry (2018 Conference) (LDN, low dose naltrexone)

 

Dana Flavin, MD - Reversing Cancer with Biochemistry (2018 Conference) (LDN, low dose naltrexone)

Dr Dana Flavin shares her presentation on Reversing Cancer at the LDN 2018 Conference.

Dr Dana Flavin's training and background are extensive: she is a scientist, doctor and knowledgeable about nutrition. She dedicates most of her time to her Cancer patients with great success. With over 30 years of experience and 10 years of utilizing Low Dose Naltrexone (LDN) along with other conventional medications and therapies, she has great success.

She continues to research every avenue of treatment, and is open-minded and curious. In this interview Dr Flavin explains the impact of cancer and how LDN has amazed her in hundreds of cases. She hopes studies will prove how effective LDN is for Cancer and other autoimmune conditions. Non Hogkin's Lymphoma. 

In this presentation Dr Flavin presents on how since beginning her research on cancer in 1980, she has been fortunate to find many therapies that are successful in reversing many varieties of cancer.

This is a summary of Dr Dana Flavin's presentation. Please listen to the rest of Dr Flavin's presentation by clicking on the video above.

To watch past conference click https://ldnresearchtrust.org/ldn-conferences